All terms in NCIT
| Label | Id | Description |
|---|---|---|
| 5-Hydroxyindoleacetic Acid Measurement | NCIT_C112217 | [The determination of the amount of 5-hydroxyindoleacetic acid present in a sample.] |
| Absolute Change From Nadir in Sum of Diameter | NCIT_C112218 | [The most recently recorded sum of diameters minus the lowest sum of diameters previously recorded.] |
| Neutrophilic Eccrine Hidradenitis | NCIT_C112211 | [Painful red or pink edematous nodules most commonly found on the palmar and/or plantar regions.] |
| Hidradenitis | NCIT_C112190 | [Inflammation of the apocrine sweat glands, characterized by redness, itching, pain or swelling of the sweat glands, usually in the axillae or groin.] |
| Onycholysis | NCIT_C112212 | [A nail condition characterized by spontaneous separation of a fingernail or toenail from its nail bed.] |
| Nail Loss | NCIT_C78494 | [Loss of all or a portion of a nail.] |
| Onychodystrophy | NCIT_C112213 | [Deformity or discoloration of a fingernail or toenail.] |
| Onychomycosis | NCIT_C112214 | [Fungal infection of a fingernail or toenail.] |
| Nail Infection | NCIT_C78493 | [An infectious process affecting the nail.] |
| Vasculitis | NCIT_C26912 | [An inflammatory process involving the wall of the vessels (large, medium, or small-sized vessels). The inflammatory process may cause necrosis or formation of granulomas in the vascular wall. It may be the result of an autoimmune disorder, infection, or malignancy. Representative examples include polyarteritis nodosa, temporal arteritis, Wegener granulomatosis, Kawasaki disease, Takayasu arteritis, and Henoch-Schonlein purpura.] |
| Senior | NCIT_C49467 | [A suffix used to distinguish a father from his son when they have the same given name.] |
| Suffix | NCIT_C49106 | [An affix occurring at the end of a word, word base, phrase, or name.] |
| GAIA Postpartum Hemorrhage Level of Diagnostic Certainty | NCIT_C126849 | [A classification of maternal and fetal outcomes relating to postpartum hemorrhage, developed by the Global Alignment of Immunization safety Assessment in pregnancy, based on the extent to which the diagnosis has been confirmed.] |
| World Health Organization Adverse Reaction Terminology | NCIT_C49468 | [A terminology for coding clinical information in relation to drug therapy, used throughout the WHO Program by member countries and around the world by pharmaceutical companies and clinical research organisations. It has been developed over more than thirty years to serve as a basis for rational coding of adverse reaction terms.] |
| Systematized Nomenclature of Medicine Clinical Terms | NCIT_C49469 | [Published by the College of American Pathologists, the Systematized Nomenclature of Medicine Clinical Terms is a combination of content of SNOMED Reference Terminology and READ codes.] |
| Second | NCIT_C49463 | [A suffix denoting the second person having the same complete name (first, middle, and family names).] |
| GAIA Preterm Birth Level of Diagnostic Certainty | NCIT_C126845 | [A classification of maternal and fetal outcomes relating to preterm birth, developed by the Global Alignment of Immunization safety Assessment in pregnancy, based on the extent to which the diagnosis has been confirmed.] |
| Third | NCIT_C49464 | [A suffix denoting the third person having the same complete name (first, middle, and family names).] |
| GAIA Stillbirth Level of Diagnostic Certainty | NCIT_C126846 | [A classification of maternal and fetal outcomes relating to stillbirth, developed by the Global Alignment of Immunization safety Assessment in pregnancy, based on the extent to which the diagnosis has been confirmed.] |
| Fourth | NCIT_C49465 | [A suffix denoting the fourth person having the same complete name (first, middle, and family names).] |